
Jason Penninger

Arian Rodrigo Hassanalizadeh
Turning promising science into something the market understands and believes in is rarely straightforward. Leila de Koster shares how Hale navigated the realities of building a novel therapeutic category from the ground up, overcoming entrenched assumptions, earning trust across investors, regulators, and the veterinary market, and reaching the development and funding milestones that demonstrate the category is real.

Leila de Koster
Nicolas Graber

Nicolas Graber
Nicolas studied business law at renowned universities in France, Germany and Switzerland and specialized in banking.
After working in the legal and compliance department of a large Zurich bank, he successfully took over the management of compliance departments of several private banks in Liechtenstein, where he supported their restructuring, digitalization and internationalization processes.
He holds certificates as a Digital Legal Officer from the University of Liechtenstein and in Corporate Governance from the University of St. Gallen/Swiss Board School.
Today, Nicolas advises companies and private individuals on compliance issues in the financial industry in Liechtenstein, teaches at the University of Liechtenstein and holds various board mandates